Catalog number: HPA005785_100ul
Brand: Atlas Antibodies
Packing: 100 ul
Other sizes: Other size available
Price: € 388.00
Expected delivery time: 7 days
Immunohistochemistry analysis in hu...
Immunohistochemical staining of hum...
Immunohistochemical staining of hum...
Immunofluorescent staining of human...
Western blot analysis in human cell...
Immunohistochemical staining of hum...
Staining of human skeletal muscle s...

Product specifications for - Anti-CD44

Product group: Antibodies
Category: Primary Antibodies
Application: ImmunoCytoChemistry; ImmunoFluorescence; ImmunoHistoChemistry; Western Blot
Species: Human
Host: Rabbit
Target: CD44
Target description: CD44 molecule (Indian blood group)
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Datasheet: Datasheet
  Research Use Only
UNSPSC: 12352203
Form supplied: The antibodies are delivered in 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage instructions: Store at +4-¦C for short term storage. Long time storage is recommended at -20-¦C.
Scientific information: 
Scientific info: Specification: This antibody has been used for staining of 48 normal human tissue samples as well as human cancer samples covering the 20 most common cancer types and up to 12 patients for each cancer type.
Gene ID: 960
Swiss prot ID: P16070
Related products: 
Related products: Corresponding Atlas Antigen: APrEST83079
Additional information: 
Synonyms: HPA005785; CD44 antigen; CDW44; cell surface glycoprotein CD44; chondroitin sulfate proteoglycan 8; CSPG8; ECMR-III; epican; extracellular matrix receptor III; GP90 lymphocyte homing/adhesion receptor; HCELL; hematopoietic cell E- and L-selectin ligand; heparan sulfate proteoglycan; Hermes antigen; homing function and Indian blood group system; HUTCH-I; hyaluronate receptor; IN; Indian blood group antigen; LHR; MC56; MDU2; MDU3; MIC4; Pgp1; phagocytic glycoprotein 1; Phagocytic glycoprotein I; soluble CD44
Asplund A, Gry Björklund M, Sundquist C, Strömberg S, Edlund K, Ostman A, Nilsson P, Pontén F, Lundeberg J. "Expression profiling of microdissected cell populations selected from basal cells in normal epidermis and basal cell carcinoma.". Br J Dermatol 2008 Mar; 158(3):527-38. Epub 2008 Jan 30. DOI: 10.1111/j.1365-2133.2007.08418.x. Read more
Twarock S, Röck K, Sarbia M, Weber A, Jänicke R, Fischer J. "Synthesis of hyaluronan in oesophageal cancer cells is uncoupled from the prostaglandin–cAMP pathway". Br J Pharmacol 2009 May; 157(2):234-243. Epub 2009 Mar 26. DOI: 10.1111/j.1476-5381.2009.00138.x. Read more
Vazquez-Martin A, Oliveras-Ferraros C, Cufí S, Del Barco S, Martin-Castillo B, Menendez JA. "Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status.". Cell Cycle 2010 Sep 15; 9(18):3807-14. Epub 2010 Sep 25. Read more
Baccelli I, Schneeweiss A, Riethdorf S, Stenzinger A, Schillert A, Vogel V, Klein C, Saini M, Bäuerle T, Wallwiener M, Holland-Letz T, Höfner T, Sprick M, Scharpff M, Marmé F, Sinn HP, Pantel K, Weichert W, Trumpp A. "Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay.". Nat Biotechnol 2013 Jun; 31(6):539-44. Epub 2013 Apr 21. DOI: 10.1038/nbt.2576. Read more
Petit V, Massonnet G, Maciorowski Z, Touhami J, Thuleau A, Némati F, Laval J, Château-Joubert S, Servely JL, Vallerand D, Fontaine JJ, Taylor N, Battini JL, Sitbon M, Decaudin D. "Optimization of tumor xenograft dissociation for the profiling of cell surface markers and nutrient transporters.". Lab Invest 2013 May; 93(5):611-21. Epub 2013 Mar 4. DOI: 10.1038/labinvest.2013.44. Read more
Lei J, Firdaus W, Rosenzweig JM, Alrebh S, Bakhshwin A, Borbiev T, Fatemi A, Blakemore K, Johnston MV, Burd I. "Murine model: maternal administration of stem cells for prevention of prematurity". Am J Obstet Gynecol 2014 Dec 30; 212(5):639.e1-639.10. Epub 2014 Dec 30. DOI: 10.1016/j.ajog.2014.12.032. Read more